Stem cell factor Sox2 and its close relative Sox3 have differentiation functions in oligodendrocytes
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Neural precursor cells of the ventricular zone give rise to all neurons and glia of the central nervous system and rely for maintenance of their precursor characteristics on the closely related SoxB1 transcription factors Sox1, Sox2 and Sox3. We show in mouse spinal cord that, whereas SoxB1 proteins are usually downregulated upon neuronal specification, they continue to be expressed in glial precursors. In the oligodendrocyte lineage, Sox2 and Sox3 remain present into the early phases of terminal differentiation. Surprisingly, their deletion does not alter precursor characteristics but interferes with proper differentiation. Although a direct influence on myelin gene expression may be part of their function, we provide evidence for another mode of action. SoxB1 proteins promote oligodendrocyte differentiation in part by negatively controlling miR145 and thereby preventing this microRNA from inhibiting several pro-differentiation factors. This study presents one of the few cases in which SoxB1 proteins, including the stem cell factor Sox2, are associated with differentiation rather than precursor functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vertebrate neurogenesis is counteracted by Sox1–3 activity
Bylund, M., Andersson, E., Novitch, B. G., & Muhr, J. (2003) · Nature Neuroscience · doi:10.1038/nn1131 · Cited by 825
Sox10, a Novel Transcriptional Modulator in Glial Cells
Kuhlbrodt, K., Herbarth, B., Sock, E., Hermans-Borgmeyer, I., & Wegner, M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00237.1998 · Cited by 781
Self-citationThe Sox9 transcription factor determines glial fate choice in the developing spinal cord
Stolt, C. C., Lommes, P., Sock, E., Chaboissier, M.-C., Schedl, A., & Wegner, M. (2003) · Genes & Development · doi:10.1101/gad.259003 · Cited by 636
Self-citationDicer1 and miR-219 Are Required for Normal Oligodendrocyte Differentiation and Myelination
Dugas, J. C., Cuellar, T. L., Scholze, A., Ason, B., Ibrahim, A., Emery, B., Zamanian, J. L., Foo, L. C., McManus, M. T., & Barres, B. A. (2010) · Neuron · doi:10.1016/j.neuron.2010.01.027 · Cited by 577
Myelin gene regulatory factor is a critical transcriptional regulator required for CNS myelination
Emery, B., Agalliu, D., Cahoy, J. D., Watkins, T. A., Dugas, J. C., Mulinyawe, S. B., Ibrahim, A., Ligon, K. L., Rowitch, D. H., & Barres, B. A. (2009) · Cell · doi:10.1016/j.cell.2009.04.031 · Cited by 559 · cited 2×
“The transcription factor Myrf and the mediator subunit Med12 constitute two such targets (Emery et al., 2009; Vogl et al., 2013).”
BackgroundMicroRNA-Mediated Control of Oligodendrocyte Differentiation
Zhao, X., He, X., Han, X., Yu, Y., Ye, F., Chen, Y., Hoang, T., Xu, X., Mi, Q.-S., Xin, M., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.02.018 · Cited by 508
Stolt, C. C., Schlierf, A., Lommes, P., Hillgärtner, S., Werner, T., Kosian, T., Sock, E., Kessaris, N., Richardson, W. D., Lefebvre, V., et al. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.08.011 · Cited by 299 · cited 3×
“Among Sox proteins, functional redundancy during oligodendrocyte development is not restricted to SoxB1 factors and has previously been observed for SoxE and SoxD proteins (Stolt et al., 2003; Stolt et al., 2004; Stolt et al., 2006; Finzsch et al., 2008).”
BackgroundSelf-citationHornig, J., Fröb, F., Vogl, M. R., Hermans-Borgmeyer, I., Tamm, E. R., & Wegner, M. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003907 · Cited by 228 · cited 1×
“…2003)], Olig2 (rabbit antiserum; 1:1000; Chemicon, AB9610), Pdgfra (rabbit antiserum; 1:300; Santa Cruz, sc-338), Myrf [rabbit antiserum; 1:1000 (Hornig et al., 2013)], Mbp (mouse monoclonal; 1:100; Boehringer Mannheim, 1118099), Plp (rabbit antiserum; 1:400; gift of K.-A. Nave, Max Planck…”
Self-citationMicroRNA Expression Profiling of Oligodendrocyte Differentiation from Human Embryonic Stem Cells
Letzen, B. S., Liu, C., Thakor, N. V., Gearhart, J. D., All, A. H., & Kerr, C. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010480 · Cited by 119
Cited by
Brain cell type–specific enhancer–promoter interactome maps and disease - risk association
Nott, A., Holtman, I. R., Coufal, N. G., Schlachetzki, J. C. M., Yu, M., Hu, R., Han, C. Z., Pena, M., Xiao, J., Wu, Y., et al. (2019) · Science · doi:10.1126/science.aay0793 · Cited by 699
Molecular Control of Oligodendrocyte Development
Elbaz, B., & Popko, B. (2019) · Trends in Neurosciences · doi:10.1016/j.tins.2019.01.002 · Cited by 293
Transcriptional Convergence of Oligodendrocyte Lineage Progenitors during Development
Marques, S., van Bruggen, D., Vanichkina, D. P., Floriddia, E. M., Munguba, H., Väremo, L., Giacomello, S., Falcão, A. M., Meijer, M., Björklund, Å. K., et al. (2018) · Developmental Cell · doi:10.1016/j.devcel.2018.07.005 · Cited by 290
Transcriptional control of myelination and remyelination
Sock, E., & Wegner, M. (2019) · Glia · doi:10.1002/glia.23636 · Cited by 109
Self-citationLahti, L., Haugas, M., Tikker, L., Airavaara, M., Voutilainen, M. H., Anttila, J., Kumar, S., Inkinen, C., Salminen, M., & Partanen, J. (2015) · Development · doi:10.1242/dev.129957 · Cited by 62
Metadata
- Authors
- Hoffmann, S. A., Hos, D., Küspert, M., Lang, R. A., Lovell-Badge, R., Wegner, M., & Reiprich, S.
- Venue
- Development
- Publisher
- The Company of Biologists
- Published
- 2014-01-01
- Volume
- 141
- Issue
- 1
- Pages
- 39-50
- ISSN
- 0950-1991 (ISSN-L)
- 1477-9129
- OpenAlex
- W2127915604
- Cited by
- 114
- References
- 9
- FWCI
- 3.66
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.